Does artificial intelligence have a role in the IVF clinic? by Chow, Darren J X et al.




Does artificial intelligence have a role in the 
IVF clinic?
Darren J X Chow1,2,3 , Philip Wijesinghe4 , Kishan Dholakia3,4,5,6  and Kylie R Dunning 1,2,3
1Robinson Research Institute, School of Biomedicine, The University of Adelaide, Adelaide, Australia
2Australian Research Council Centre of Excellence for Nanoscale Biophotonics, The University of Adelaide, Adelaide, Australia
3Institute for Photonics and Advanced Sensing, The University of Adelaide, Adelaide, Australia
4SUPA, School of Physics and Astronomy, University of St Andrews, North Haugh, St Andrews, Fife, United Kingdom
5School of Biological Sciences, The University of Adelaide, Adelaide, Australia
6Department of Physics, College of Science, Yonsei University, Seoul, South Korea
Correspondence should be addressed to K R Dunning: kylie.dunning@adelaide.edu.au
Lay summary
The success of IVF has remained stagnant for a decade. The focus of a great deal of research is to improve on the current 
~30% success rate of IVF. Artificial intelligence (AI), or machines that mimic human intelligence, has been gaining traction 
for its potential to improve outcomes in medicine, such as cancer diagnosis from medical images. In this commentary, we 
discuss whether AI has the potential to improve fertility outcomes in the IVF clinic. Based on existing research, we examine 
the potential of adopting AI within multiple facets of an IVF cycle, including egg/sperm and embryo selection, as well as 
formulation of an IVF treatment regimen. We discuss both the potential benefits and concerns of the patient and clinician 
in adopting AI in the clinic. We outline hurdles that need to be overcome prior to implementation. We conclude that AI has 
an important future in improving IVF success.
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Introduction
The birth of the first baby conceived using in vitro 
fertilisation (IVF) occurred more than four decades 
ago. Since then, there have been many advances in IVF 
including personalised ovarian stimulation, extended 
embryo culture at physiological oxygen, and a move 
to single embryo transfer. However, for many infertile 
patients, the journey to parenthood via IVF is a lengthy 
and emotionally and financially challenging process.
For some patients, IVF will not lead to the birth of a 
baby. The focus of a great deal of research is to improve 
on the current ~30% success rate of IVF (De Geyter  et  al. 
2020). Further advancements are likely in areas including 
patient-specific treatment regimen, improved gamete, and 
embryo selection, as well as improving endometrial 
receptivity and management of early pregnancy. 
Interestingly, variation in IVF success exists between 
operators and clinics. Such variation likely exists due to the 
subjectivity of current assessments. One such assessment is 
the grading and selection of embryos for transfer based on 
morphological features.
Recently, the use of artificial intelligence (AI) has 
gained traction in its ability to predict clinical outcomes 
using routinely obtained information, such as patient 
attributes, medical images, and blood test results. In turn, 
this has led to its demonstrated use in accurately classifying 
the severity of cancer using medical images (Esteva  et  al. 
2017, Yamashita et al. 2021). Here, we consider whether AI 
has a place in the IVF clinic. Can AI deliver assessments 
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Artificial intelligence; machine learning; 
deep learning; neural networks: what’s 
the difference?
To explore the potential application of AI, we have to first 
define it, and how it differs from machine learning and deep 
learning technologies (Fig. 1). AI is an umbrella term that 
describes machines that aim to mimic human or animal 
cognitive capacity. Machine learning is a subset of the 
broader AI technology that learns its processing from data 
without explicit programming. It can predict outcomes 
for tasks that comprise many parameters and that would 
be too time-consuming (or impossible) for a person to 
perform. Deep learning is a further subset of machine 
learning. It utilises artificial neural networks (ANN) which 
mimic the architecture of neurons in the brain. Deep 
neural networks, those that comprise many layers of 
neurons, can perform any conceivable computation if the 
precise neuron connections are activated via training. This 
capacity alone has integrated deep learning across broad 
advances in science and technology. Deep learning can 
be further classified as either supervised or unsupervised. 
Supervised learning guides networks to generate outputs 
consistent with some label or ground truth, whilst 
unsupervised learning infers features from some inherent 
structure in the data. There are many ANN architectures, 
with increasingly more sophisticated systems being 
developed, from fully connected networks that can make 
predictions from unstructured data to convolutional 
networks that excel in image classification, to recurrent 
networks that make predictions based on temporally 
evolving data. An exposition on ANNs is beyond the scope 
of the current commentary and we direct the reader to a 
recent in-depth review (Fernandez  et  al. 2020). For the 
purpose of this article, we will use AI as the umbrella term 
to describe the mathematical algorithms that endeavour to 
automate any decision or analysis performed by a clinician 
or embryologist.
Use of AI in image classification
Optical imaging is at the fore with regard to many clinical 
diagnoses and is an area where AI can assist. A positive 
attribute for AI is that once it is trained, the inference (i.e. 
the processing of data through a trained network) is non-
iterative and very fast to compute, obviating the need for 
a parameter search. This gives advantages in speed and 
implementation. Evaluation of networks has been well-
integrated with contemporary devices and can be done on 
servers, using cloud services, and even on mobile phones.
When using optical imaging, clinicians are faced with 
the challenge of having different imaging equipment 
both within and between institutions. This yields images 
of varying quality (i.e. resolution, contrast, etc.) making 
standardisation of assessments challenging. For a recent 
review and future trends of the area of deep learning for 
microscopy, see Wijesinghe & Dholakia 2021. For instance, 
subjectivity in clinical assessment is a major issue for 
cancer treatment. Different operators often yield different 
diagnoses from the same set of images. Multi-dimensional 
imaging, such as time-lapse or 3D imaging, presents a 
further issue where the clinician is unable to analyse and 
interpret the data at once from one static image and must 
rely on memory and contextual information. Adopting AI 
could aid clinicians in these aspects – is the same true for 
clinical IVF?
Adopting AI within the fertility clinic could lead 
to a major increase in IVF success. For example, AI could 
potentially aid the embryologist in providing rapid, 
objective, and accurate assessment of gamete and embryo 
Figure 1 Hierachy of information processing theories in the computer 
science field. Artificial intelligence (AI) is an umbrella term attributed to 
the primary objective within the field of computer science to develop 
machines with intelligence. Machine learning describes approaches to 
achieve AI that learns from experience without explicit programming. 
Deep learning is a form of machine learning that utilises artificial neural 
networks to extract, process, and predict information by learning from 
examples. It is commonly applied in the scientific field, in particular, in 
image classification.
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health. AI may also aid physicians in formulating an 
optimal, personalised fertility treatment plan based on 
patient characteristics. Supervised AI approaches are 
the norm at present and are primarily data-driven. Here, 
AI outputs are trained against known ground truths. 
Unsupervised AI, which is not reliant on label-based 
feedback, may be an attractive alternative. For this case, 
the network infers the internal structure of the input data, 
often through some policy of rewards for the outcome – as a 
result, the optical imaging takes on a form of 'intelligence' 
in the clinical decision-making process.
Role of AI in IVF
AI will likely demonstrate utility in several facets of the 
IVF procedure. Below, we discuss some of the more recent 
literature on the use of AI in gamete and embryo selection 
as well as the development of a treatment regimen (Fig. 2).
AI in gamete selection
Current clinical assessment of gamete health is focused 
on identifying early markers of quality. This includes 
visualisation of gametes either through direct inspection 
or via static images or time-lapse videos. The quality of 
female gametes is associated with follicle size, oocyte 
morphology, and cytoplasmic characteristics. In terms 
of sperm, morphology, concentration, and motility are 
known factors that are directly correlated with IVF success. 
However, the selection is prone to a high degree of variation 
between operators. AI can be transformative in this aspect. 
AI would remove the subjectivity of human assessment 
from the decision-making process, and objectively 
rank gametes based on quality. The use of AI for oocyte 
selection may be limited due to the practice of fertilising all 
available oocytes. Unless of course, AI was able to predict 
blastocyst formation or more importantly, live birth prior 
to fertilisation. Such capacity appears limited based on 
the current literature (Manna  et  al. 2013). The greatest 
benefit of AI may come from the selection of sperm for 
intracytoplasmic sperm injection (ICSI), a process currently 
performed by the embryologist. The development of new 
assessment criteria for sperm selection might arise through 
the use of unsupervised AI, where new markers of sperm 
quality are identified, such as swimming patterns, direction 
of motion, or difference in sperm compartments (i.e. 
length of head vs tail). Although more challenging, AI may 
compute the optimal sperm–egg combination to achieve 
the highest success rate or perhaps determine whether 
IVF or ICSI is the best fertilisation approach. Interestingly, 
AI has demonstrated proficiency in predicting fertility 
outcomes based on distinct ultrastructural details of mouse 
sperm – a larger sperm head compared to the midpiece 
is associated with improved blastocyst development 
(Kandel et al. 2020). Similarly, AI has yielded high accuracy 
in classifying human sperm using kinetic parameters – 
89.9% (Goodson  et  al. 2017); as well as classifying sperm 
head morphology with a high concordance rate with 
current manual classifications (SCIAN and HuSHeM, 88 
and 94%, respectively) (Iqbal  et  al. 2020). Notably, these 
studies used images or videos acquired during a routine 
assessment. AI can, therefore, complement current clinical 
practices whilst offering objective gamete selection to 
substantiate the assessment made by embryologists.
AI in embryo selection
Morphological assessment of embryos is the most 
commonly used process to select embryos for transfer. This 
occurs through direct visualisation using a light microscope 
or by time-lapse imaging. Both approaches grade embryos 
on their ability to reach particular stages of development in 
a timely manner. As with gamete selection, there is a high 
Figure 2 Emerging role of artificial intelligence (AI) in the in vitro 
fertilisation (IVF) clinic. AI represents an opportunity for technological 
advancement to improve IVF success. It is multifaceted in its capability. 
For example, AI may aid in selecting the best oocyte and sperm 
combination as well as predicting embryo quality. Furthermore, AI may 
assist the clinician in developing an optimal patient-specific treatment 
regimen to improve IVF success.
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degree of variation between operators and clinics due to 
the subjective nature of these assessments. Consequently, 
standardisation is challenging within a clinic and near-
impossible between institutions. As such, morphological 
grading remains limited in its ability to predict live birth 
outcomes (Chen et al. 2017). AI, using routinely generated 
images or time-lapse videos, may objectively and accurately 
grade and rank embryos, thus, assisting in the decision-
making process to transfer or freeze them. Further, AI 
may have a role in analysing data from non-invasive 
metabolomic and secretory profiles from the embryo 
during culture. Consequently, this may lead to improved 
culture media formulations and regimens.
Studies using AI to predict embryo developmental 
competence are on the rise, as reviewed in Fernandez et al. 
(2020). These show promise in improving the accuracy of 
manual grading and predicting development to blastocyst 
and pregnancy (Chavez-Badiola et al. 2020, VerMilyea et al. 
2020, Coticchio et al. 2021). Interestingly, AI is able to use 
cellular textures to accurately discern between the inner 
cell mass (fetal lineage, 91% accuracy) and trophectoderm 
(placental lineage, 86.6% accuracy) of the blastocyst 
(Saeedi et al. 2017). The use of AI to accurately identify cell 
lineages may lead to improved embryo classification and 
IVF success. However, whether AI can accurately predict the 
live birth outcome to a high degree, for example, in excess 
of 80–90% is yet to be demonstrated. However, a recent 
study has yielded a 69.3% accuracy (Vogiatzi et al. 2019). In 
summary, the implementation of AI in the embryo grading 
and selection process could provide an objective and 
accurate prediction of pregnancy and live birth outcomes.
AI in treatment regimen
In the IVF clinic, decision-making for an IVF cycle regimen 
is guided by patient age, gamete quality, medical history, 
and many more. This process intends to maximise the 
chances of pregnancy and birth of a healthy baby. From 
patient to patient, an IVF cycle might thus differ in 
stimulation protocol and mode of fertilisation (IVF vs 
intracytoplasmic sperm injection) as well as the potential 
for other procedures including assisted hatching and 
preimplantation genetic testing, amongst others. Planning 
for an IVF cycle is heavily reliant upon input from the 
clinician, who may prescribe a different treatment regimen 
based on their own clinical experience and/or clinic-to-
clinic differences in training and in-house practice. AI 
could aid fertility practitioners in this aspect, enabling 
objective decision-making to optimise the treatment 
protocol for the best outcome. AI could also be applied 
to data-mine existing patient records to discover novel 
markers that predict pregnancy and live birth. Indeed, the 
use of AI in other fields such as oncology is very promising 
in this regard with a significant reduction in time required 
to formulate radiotherapy treatment plans (from days to 
minutes) (Wang  et  al. 2019). Interestingly, the use of AI 
to data-mine existing databases led to the identification 
of novel genes associated with the pathogenesis of 
endometriosis (Bouaziz  et  al. 2018). Incorporating AI 
within this aspect of the IVF cycle might lead to improved 
success as well as the reduced workload for clinicians.
Artificial intelligence: is there a limit?
Artificial intelligence promises a revolutionary change 
in the field of medicine, including the IVF clinic. There 
are, however, major challenges to overcome before AI can 
take centre-stage in IVF treatments. First is the onus of 
the ground truth or target for learning. To date, the vast 
majority of publications have utilised positive pregnancy 
test as the metric of success. It is our opinion that the most 
appropriate and patient-centred target is the birth of a 
healthy child. In time to come, this may shift to include 
the health of IVF-conceived children later in life. A further 
challenge facing learning AI is that they evolve with 
data, lacking transparency and interpretability to their 
inner workings – often approached with apprehension as 
'black box' machines. Major advances in the past decade 
have enabled us to disentangle, guide, and evaluate AI. 
However, an explicit understanding of trained algorithms 
is unintuitive as, ultimately, we expect AI to supersede the 
capacity of ‘human intelligence’. AI mandates a regulatory 
and perhaps a mentality change in the clinic, wherein 
algorithms are not expected to be infallible but rather 
embracing the essential part of all ‘intelligence’ – the 
capacity to make and learn from mistakes. Aside from this, 
the required magnitude of data to train AI to achieve high 
accuracy and reliability is proportionally large to the extent 
of predictive accuracy and is also dependent on data quality. 
Therefore, AI may be ideal for clinics with an existing 
large patient database but may disadvantage others with 
smaller patient populations. This can be circumvented 
with a unified registry at a national or international level 
to minimise potential selection bias commonly seen with 
small data sets. On the flip side, the use of a unified AI 
and centralised data may predispose the electronic health 
system to potential data breaches or, potentially, may 
encourage some to optimise their digital information to 
influence AI outcomes. If AI generates a metric of quality 
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for a clinic, patients will likely seek out the best one. In an 
example of Goodhart’s Law, clinics may try to optimise 
their 'AI score' by modifying the parameters that they 
report, or make them reluctant to treat 'riskier' patients 
in an effort to improve or retain their scores. Moreover, AI 
often requires re-training when switching from one sample 
to another, or when switching from one imaging modality 
to another, which can be both time-consuming and costly. 
Nonetheless, this may be overcome through unsupervised 
reinforcement learning, where the algorithm itself is able 
to learn how to extract features with optimal predictive 
accuracy for application in the medical field.
Future directions
Despite the challenges, it is undeniable that AI has a 
future role in the IVF field. However, AI must overcome 
hurdles prior to its utilisation (Table 1). AI requires not 
only extensive simulation studies and publication in 
peer-reviewed journals but also rigorous validation in 
numerous clinics and in different patient populations. 
More broadly in the clinical domain, amongst an 
extensive list of medical algorithms approved by the US 
Food & Drugs Administration (FDA) (Benjamens  et  al. 
2020), only a handful of these are supported by peer-
reviewed publications. It also highlights the need for more 
rigorous scrutiny and peer-reviewed evidence for future 
AI algorithm applications given the recent relaxation 
of FDA regulatory requirements for medical algorithm 
approval (Benjamens  et  al. 2020). Thus, we should 
evaluate AI not only by the capacity to enhance existing 
clinical assessments but on their ultimate improvement 
to real clinical targets, such as live birth. Nonetheless, 
it is an exciting journey that lies ahead. For the case of 
optimising an IVF cycle, AI will likely aid clinicians in 
devising patient-specific treatment regimens, before and 
after oocyte collection, as well as improving gamete and 
embryo selection. The integration of this new technology 
is well-positioned to improve IVF, promising an increase 
in the current and stagnant success rate. The continued 
emergence of AI studies will benefit the IVF industry and 
most importantly, patient’s affected by infertility.
Conclusion
Incorporating AI technology into the IVF clinic may be 
the next frontier in the journey towards personalised 
reproductive medicine and improved fertility outcomes for 
patients. Infertility, as a global burden of disease, continues 
to rise (Sun et al. 2019). Furthermore, it is predicted that the 
global population will decline below replacement levels in 
the near future (Vollset et al. 2020). Additionally, the recent 
global COVID19 pandemic has delayed childbearing and 
fertility treatment for many. Thus, there will be an expected 
increase in demand for IVF moving forward. With the 
success of IVF stagnant for the past decade, AI is well placed 
to improve and enhance current clinical practices and the 
predictive power of IVF outcomes. This will undoubtedly 
benefit patients and ensure the next generation of healthy 
individuals conceived through IVF.
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Table 1 Steps toward adoption of AI in the IVF clinic.
Hurdles Requirements to develop AI in the infertility service
 • Most clinics are too small in isolation to have sufficient data  
for AI
 • Limited computing power and data storage
 • Discrepancy in recorded and reported patient characteristics  
and reproductive outcomes between clinics
 • Variation between studies in the input parameters used for AI  
to predict reproductive outcomes 
 • Consortia to develop standardised and detailed recording 
and reporting of patient data
 • Multi-clinic sharing of anonymised patient data
 • Increased computing power and data storage
 • Consensus on input parameters used in AI for predicting 
reproductive outcomes
 • Rigorous, high quality, multi-centre, peer-reviewed 
validation studies for AI algorithms
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